Lipid Polymer Hybrid Nanomaterials for mRNA Delivery
- 19 June 2018
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Bioengineering
- Vol. 11 (5) , 397-406
Abstract
In the past decade, messenger RNA (mRNA) has been extensively explored in a wide variety of biomedical applications. However, efficient delivery of mRNA is still one of the key challenges for its broad applications in the clinic. Recently, lipid polymer hybrid nanoparticles (LPNs) are evolving as a promising class of biomaterials for RNA delivery, which integrate the physicochemical properties of both lipids and polymers. We previously developed an N1,N3,N5-tris(2-aminoethyl)benzene-1,3,5-tricarboxamide (TT) derived lipid-like nanomaterial (TT3-LLN) which was capable of effectively delivering multiple types of mRNA. In order to further improve the delivery efficiency of TT3-LLN, in this study, we focused on studying the effects of incorporating different polymers on establishing LPNs and aimed to develop an optimized lipid polymer hybrid nanomaterial for efficient mRNA delivery.Keywords
Funding Information
- National Institute of General Medical Sciences (1R35GM119679)
This publication has 35 references indexed in Scilit:
- Mammalian synthetic circuits with RNA binding proteins for RNA-only deliveryNature Biotechnology, 2015
- Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatmentProceedings of the National Academy of Sciences, 2015
- mRNA-based therapeutics — developing a new class of drugsNature Reviews Drug Discovery, 2014
- Direct observation of liquid crystals using cryo‐TEM: Specimen preparation and low‐dose imagingMicroscopy Research and Technique, 2014
- In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightNature Nanotechnology, 2014
- Lipid–polymer hybrid nanoparticles as a new generation therapeutic delivery platform: A reviewEuropean Journal of Pharmaceutics and Biopharmaceutics, 2013
- Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarctionNature Biotechnology, 2013
- PLGA-based nanoparticles: An overview of biomedical applicationsJournal of Controlled Release, 2012
- Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate CancerNano Letters, 2011
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011